| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| KECK KIM | Director | C/O EVOLENT HEALTH, INC., 1812 N. MOORE ST., STE. 1705, ARLINGTON | /s/ Jonathan Weinberg, Attorney-in-fact | 2025-06-09 | 0001818332 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EVH | Class A Common Stock | Award | $0 | +22K | +55.61% | $0.00 | 61.5K | Jun 5, 2025 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Represents restricted stock units granted to Ms. Keck pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. |
| F2 | Securities vest on the earlier of June 5, 2026, and the date of the Company's 2026 annual meeting, subject to the reporting person's continued service on the vesting date. |